Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3168)
All Articles published online
|
Dec 7, 2011 (publication date) through Nov 27, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Maharshak N, Halfon P, Deutsch V, Peretz H, Berliner S, Fishman S, Zelber-Sagi S, Rozovski U, Leshno M, Oren R. Increased fibrosis progression rates in hepatitis C patients carrying the prothrombin G20210A mutation. World J Gastroenterol 2011; 17(45): 5007-5013 [PMID: 22174551 DOI: 10.3748/wjg.v17.i45.5007] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v17/i45/5007.htm |
| Number | Citing Articles |
| 1 |
Mattias Mandorfer, Annalisa Berzigotti. Portal Hypertension VII. 2022; : 29 doi: 10.1007/978-3-031-08552-9_4
|
| 2 |
Martin Zalesak, Kevin Francis, Alex Gedeon, John Gillis, Kyle Hvidsten, Phyllis Kidder, Hong Li, Derek Martyn, Leslie Orne, Amanda Smith, Ann Kwong, Yury E. Khudyakov. Current and Future Disease Progression of the Chronic HCV Population in the United States. PLoS ONE 2013; 8(5): e63959 doi: 10.1371/journal.pone.0063959
|
| 3 |
Jessica P.E. Davis, Stephen H. Caldwell. Healing gone wrong: convergence of hemostatic pathways and liver fibrosis?. Clinical Science 2020; 134(16): 2189 doi: 10.1042/CS20191102
|
| 4 |
Mario D'Amico, Francesca Pasta, Linda Pasta. Thrombophilic genetic factors PAI-1 4G-4G and MTHFR 677TT as risk factors of alcohol, cryptogenic liver cirrhosis and portal vein thrombosis, in a Caucasian population. Gene 2015; 568(1): 85 doi: 10.1016/j.gene.2015.05.034
|
| 5 |
Elisabeth P. C. Plompen, Jeoffrey N. L. Schouten, Harry L. A. Janssen. Role of anticoagulant therapy in liver disease. Hepatology International 2013; 7(2): 369 doi: 10.1007/s12072-013-9427-2
|
| 6 |
María Monereo Muñoz, Selena Gala Aguilera García, Raquel de la Barreda Heusser, Emilio González Arnay, Sonia García Hernández, Emilio González Reimers. Cryptogenetic liver cirrhosis and prothrombotic mutations - A mere association?. Revista Española de Enfermedades Digestivas 2016; doi: 10.17235/reed.2016.3871/2015
|
| 7 |
L.G. Poole, A. Pant, K.S. Baker, A.K. Kopec, H.M. Cline‐Fedewa, S.E. Iismaa, M.J. Flick, J.P. Luyendyk. Chronic liver injury drives non‐traditional intrahepatic fibrin(ogen) crosslinking via tissue transglutaminase. Journal of Thrombosis and Haemostasis 2019; 17(1): 113 doi: 10.1111/jth.14330
|
| 8 |
Niccolò Bitto, Eleonora Liguori, Vincenzo La Mura. Coagulation, Microenvironment and Liver Fibrosis. Cells 2018; 7(8): 85 doi: 10.3390/cells7080085
|
| 9 |
Lauren G. Poole, Asmita Pant, Holly M. Cline‐Fedewa, Kurt J. Williams, Bryan L. Copple, Joseph S. Palumbo, James P. Luyendyk. Liver fibrosis is driven by protease‐activated receptor‐1 expressed by hepatic stellate cells in experimental chronic liver injury. Research and Practice in Thrombosis and Haemostasis 2020; 4(5): 906 doi: 10.1002/rth2.12403
|
| 10 |
Linda Pasta, Francesca Pasta. PAI-1 4G-4G and MTHFR 677TT in non-hepatitis C virus/hepatitis B virus-related liver cirrhosis. World Journal of Hepatology 2015; 7(29): 2920-2926 doi: 10.4254/wjh.v7.i29.2920
|
| 11 |
Jann‐Inn Tzeng, Mei‐Fen Chen, Hsien‐Hui Chung, Juei‐Tang Cheng. Silymarin Decreases Connective Tissue Growth Factor to Improve Liver Fibrosis in Rats Treated with Carbon Tetrachloride. Phytotherapy Research 2013; 27(7): 1023 doi: 10.1002/ptr.4829
|
| 12 |
Emilio González-Reimers, Geraldine Quintero-Platt, Candelaria Martín-González, Onán Pérez-Hernández, Lucía Romero-Acevedo, Francisco Santolaria-Fernández. Thrombin activation and liver inflammation in advanced hepatitis C virus infection. World Journal of Gastroenterology 2016; 22(18): 4427-4437 doi: 10.3748/wjg.v22.i18.4427
|
| 13 |
Johanna Ohlendorf, Hella Kiene, Jessica Wiegandt, André Karch, Veronika K. Jaeger, Tobias Laue, Norman Junge, Frauke Mutschler, Imeke Goldschmidt, Eva-Doreen Pfister, Christoph Leiskau, Claus Petersen, Omid Madadi-Sanjani, Joachim Friedrich Kuebler, Juliane Katharina Götz, Ulrich Baumann. The Impact of Thrombophilic Factors on Disease Progression in Children with Biliary Atresia—A Single-Centre Cohort Study. Journal of Clinical Medicine 2023; 12(6): 2108 doi: 10.3390/jcm12062108
|
| 14 |
Asmita Pant, Anna K. Kopec, James P. Luyendyk. Role of the blood coagulation cascade in hepatic fibrosis. American Journal of Physiology-Gastrointestinal and Liver Physiology 2018; 315(2): G171 doi: 10.1152/ajpgi.00402.2017
|
| 15 |
Jessica P. E. Davis, Amy G. Ogurick, Carrie E. Rothermel, Min-Woong Sohn, Nicolas M. Intagliata, Patrick G. Northup. Anticoagulation and Transjugular Intrahepatic Portosystemic Shunting for Treatment of Portal Vein Thrombosis in Cirrhosis: A Systematic Review and Meta-Analysis. Clinical and Applied Thrombosis/Hemostasis 2019; 25 doi: 10.1177/1076029619888026
|
| 16 |
Claude Lentschener, Claire Flaujac, Firas Ibrahim, Isabelle Gouin-Thibault, Marie Bazin, Philippe Sogni, Charles-Marc Samama. Assessment of haemostasis in patients with cirrhosis. European Journal of Anaesthesiology 2016; 33(2): 126 doi: 10.1097/EJA.0000000000000322
|
| 17 |
Elisabeth P.C. Plompen, Sarwa Darwish Murad, Bettina E. Hansen, Daan W. Loth, Jeoffrey N.L. Schouten, Pavel Taimr, Albert Hofman, André G. Uitterlinden, Bruno H. Stricker, Harry L.A. Janssen, Frank W.G. Leebeek. Prothrombotic genetic risk factors are associated with an increased risk of liver fibrosis in the general population. Journal of Hepatology 2015; 63(6): 1459 doi: 10.1016/j.jhep.2015.07.026
|
| 18 |
Mary Naguib, Wael Abdel-Razek, Suzanne Estaphan, Eman Abdelsameea, Mohamed Abdel-Samiee, Nevine F. Shafik, Roza Chaireti. Impact of prothrombin and factor V Leiden mutations on the progression of fibrosis in patients with chronic hepatitis C. PLOS ONE 2022; 17(11): e0276592 doi: 10.1371/journal.pone.0276592
|
| 19 |
Laura Turco, Filippo Schepis, Erica Villa. The Role of Anticoagulation in Treating Portal Hypertension. Current Hepatology Reports 2018; 17(3): 200 doi: 10.1007/s11901-018-0406-x
|
| 20 |
Levent Filik. Factor XIII Val34Leu mutation and liver fibrosis rate in viral hepatitis. Hepatology Research 2012; 42(11): 1154 doi: 10.1111/j.1872-034X.2012.01042.x
|
| 21 |
E E Starostina, L M Samokhodskaya, T P Rozina, T N Krasnova, E B Yarovaya, N A Mukhin. Role of polymorphic markers for the genes of hemostasis and platelet receptors in liver fibrosis progression in patients with chronic hepatitis C. Terapevticheskii arkhiv 2016; 88(8): 93 doi: 10.17116/terarkh201688893-98
|
| 22 |
Iranzu Ezcurra, Ángela Puente, Antonio Cuadrado, Ibai Tamayo, Paula Iruzubieta, María Teresa Arias‐Loste, Francisco José González, Raúl Pellón, Sara Sánchez, Juan Crespo, Mercedes Acebo, Marcos López‐Hoyos, Rocío Pérez, Amalia Cuesta, Ángela Antón, Víctor Echavarría, Emilio Fábrega, Javier Crespo, Jose Ignacio Fortea. No evidence of association between inherited thrombophilia and increased risk of liver fibrosis. United European Gastroenterology Journal 2023; 11(10): 1010 doi: 10.1002/ueg2.12500
|